Real estate group creating $1.1B gene therapy CDMO at former GSK site
The real estate impresario that built a chain of upscale drug recovery facilities is now jumping on a new trend. Brian O’Neil’s MLP Ventures says it is creating a CDMO and building a $1.1 billion gene and cell treatment manufacturing operation in a former GlaxoSmithKline site near Philadelphia.
The Center for Breakthrough Medicines will be located at The Discovery Labs, the 1.6 million-square-foot bioscience co-working space MLP is developing in the former GSK facilities is slated to occupy about 40% of that space. MLP has partnered with Deerfield Management Company on the project.
The Discovery Labs chairman is Marco A. Chacón, who last year sold his Paragon Bioservices gene therapy CDMO to Catalent for $1.2 billion…